Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TPG
Pharma
After M&A rumors, Bausch + Lomb confirms it's exploring a sale
Bausch + Lomb said that its board has authorized management to pursue its sale. The statement came in response to inquiries about its volatile stock.
Kevin Dunleavy
Dec 12, 2024 11:26am
Cash-desperate Valeant talks $10B Salix deal with Takeda: WSJ
Nov 1, 2016 10:14pm
Hepalink joins again with TPG on biotech fund
Jun 19, 2016 3:32pm
Valeant turned down Takeda-TPG takeover offer: WSJ
May 27, 2016 8:26am